Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

Prospective Evaluation of Pasireotide in Patients Undergoing Pancreaticoduodenectomy: The Washington University Experience.

Dominguez-Rosado I, Fields RC, Woolsey CA, Williams G, Horwedel TA, Rose JB, Hammill CW, Doyle MB, Chapman WC, Strasberg SM, Hawkins WG, Sanford DE.

J Am Coll Surg. 2018 Feb;226(2):147-154.e1. doi: 10.1016/j.jamcollsurg.2017.10.021. Epub 2017 Nov 11.

PMID:
29133263
2.

Pasireotide for postoperative pancreatic fistula.

Allen PJ, Gönen M, Brennan MF, Bucknor AA, Robinson LM, Pappas MM, Carlucci KE, D'Angelica MI, DeMatteo RP, Kingham TP, Fong Y, Jarnagin WR.

N Engl J Med. 2014 May 22;370(21):2014-22. doi: 10.1056/NEJMoa1313688. Erratum in: N Engl J Med. 2014 Jul 3; 371(1):94.

3.

The Cost of Postoperative Pancreatic Fistula Versus the Cost of Pasireotide: Results from a Prospective Randomized Trial.

Ma LW, Dominguez-Rosado I, Gennarelli RL, Bach PB, Gonen M, D'Angelica MI, DeMatteo RP, Kingham TP, Brennan MF, Jarnagin WR, Allen PJ.

Ann Surg. 2017 Jan;265(1):11-16. doi: 10.1097/SLA.0000000000001892.

4.

Pasireotide does not prevent postoperative pancreatic fistula: a prospective study.

Elliott IA, Dann AM, Ghukasyan R, Damato L, Girgis MD, King JC, Hines OJ, Reber HA, Donahue TR.

HPB (Oxford). 2018 May;20(5):418-422. doi: 10.1016/j.hpb.2017.10.018. Epub 2018 Feb 3.

PMID:
29398424
5.

Pasireotide is not effective in reducing the development of postoperative pancreatic fistula.

Young S, Sung ML, Lee JA, DiFronzo LA, O'Connor VV.

HPB (Oxford). 2018 Sep;20(9):834-840. doi: 10.1016/j.hpb.2018.03.007. Epub 2018 Jul 29.

PMID:
30060910
6.

Pasireotide for the Prevention of Pancreatic Fistula Following Pancreaticoduodenectomy: A Cost-effectiveness Analysis.

Goyert N, Eeson G, Kagedan DJ, Behman R, Lemke M, Hallet J, Mittmann N, Law C, Karanicolas PJ, Coburn NG.

Ann Surg. 2017 Jan;265(1):2-10. doi: 10.1097/SLA.0000000000001889.

PMID:
27537539
7.
8.

Clinical evaluation of somatostatin use in pancreatic resections: Clinical efficacy or limited benefit?

Anderson RJ, Dunki-Jacobs E, Callender GG, Burnett N, Scoggins CR, McMasters KM, Martin RC 2nd.

Surgery. 2013 Oct;154(4):755-60; discussion 760. doi: 10.1016/j.surg.2013.07.001.

PMID:
24074412
9.

Systematic review and meta-analysis of somatostatin analogues in the prevention of postoperative complication after pancreaticoduodenectomy.

Jin K, Zhou H, Zhang J, Wang W, Sun Y, Ruan C, Hu Z, Wang Y.

Dig Surg. 2015;32(3):196-207. Review.

10.

Outcomes after Pancreatectomy with Routine Pasireotide Use.

Kunstman JW, Goldman DA, Gönen M, Balachandran VP, D'Angelica MI, Kingham TP, Jarnagin WR, Allen PJ.

J Am Coll Surg. 2019 Feb;228(2):161-170.e2. doi: 10.1016/j.jamcollsurg.2018.10.018. Epub 2018 Nov 7.

PMID:
30414453
11.

Prophylactic pasireotide administration following pancreatic resection reduces cost while improving outcomes.

Abbott DE, Sutton JM, Jernigan PL, Chang A, Frye P, Shah SA, Schauer DP, Eckman MH, Ahmad SA, Sussman JJ.

J Surg Oncol. 2016 Jun;113(7):784-8. doi: 10.1002/jso.24239. Epub 2016 Apr 4.

PMID:
27041733
12.

Does type of pancreaticojejunostomy after pancreaticoduodenectomy decrease rate of pancreatic fistula? A randomized, prospective, dual-institution trial.

Berger AC, Howard TJ, Kennedy EP, Sauter PK, Bower-Cherry M, Dutkevitch S, Hyslop T, Schmidt CM, Rosato EL, Lavu H, Nakeeb A, Pitt HA, Lillemoe KD, Yeo CJ.

J Am Coll Surg. 2009 May;208(5):738-47; discussion 747-9. doi: 10.1016/j.jamcollsurg.2008.12.031.

PMID:
19476827
13.

Does fibrin glue sealant decrease the rate of pancreatic fistula after pancreaticoduodenectomy? Results of a prospective randomized trial.

Lillemoe KD, Cameron JL, Kim MP, Campbell KA, Sauter PK, Coleman JA, Yeo CJ.

J Gastrointest Surg. 2004 Nov;8(7):766-72; discussion 772-4.

PMID:
15531229
14.

[The clinical value of pancreatic fistula risk predicting system after pancreaticoduodenectomy].

Yang J, Huang Q, Lin X, Liu C, Hu J, Li R, Wang C.

Zhonghua Wai Ke Za Zhi. 2015 Jun 1;53(6):410-4. Chinese.

PMID:
26359052
15.
16.

Does pancreatic duct stenting decrease the rate of pancreatic fistula following pancreaticoduodenectomy? Results of a prospective randomized trial.

Winter JM, Cameron JL, Campbell KA, Chang DC, Riall TS, Schulick RD, Choti MA, Coleman J, Hodgin MB, Sauter PK, Sonnenday CJ, Wolfgang CL, Marohn MR, Yeo CJ.

J Gastrointest Surg. 2006 Nov;10(9):1280-90; discussion 1290.

PMID:
17114014
17.

A prospectively validated clinical risk score accurately predicts pancreatic fistula after pancreatoduodenectomy.

Callery MP, Pratt WB, Kent TS, Chaikof EL, Vollmer CM Jr.

J Am Coll Surg. 2013 Jan;216(1):1-14. doi: 10.1016/j.jamcollsurg.2012.09.002. Epub 2012 Nov 2.

PMID:
23122535
18.

Randomized clinical trial of pancreaticogastrostomy versus pancreaticojejunostomy on the rate and severity of pancreatic fistula after pancreaticoduodenectomy.

Figueras J, Sabater L, Planellas P, Muñoz-Forner E, Lopez-Ben S, Falgueras L, Sala-Palau C, Albiol M, Ortega-Serrano J, Castro-Gutierrez E.

Br J Surg. 2013 Nov;100(12):1597-605. doi: 10.1002/bjs.9252.

PMID:
24264781
19.

External stenting of pancreaticojejunostomy anastomosis and pancreatic duct after pancreaticoduodenectomy.

Kaman L, Nusrath S, Dahiya D, Duseja A, Vyas S, Saini V.

Updates Surg. 2012 Dec;64(4):257-64. doi: 10.1007/s13304-012-0178-8. Epub 2012 Sep 18.

PMID:
22987013
20.

External pancreatic duct stent decreases pancreatic fistula rate after pancreaticoduodenectomy: prospective multicenter randomized trial.

Pessaux P, Sauvanet A, Mariette C, Paye F, Muscari F, Cunha AS, Sastre B, Arnaud JP; Fédération de Recherche en Chirurgie (French).

Ann Surg. 2011 May;253(5):879-85. doi: 10.1097/SLA.0b013e31821219af.

PMID:
21368658

Supplemental Content

Support Center